The global clinical chemistry analyzers market was valued at USD 18.63 billion in 2023 and is projected to reach USD 25.88 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2030. The expansion of this market is significantly driven by the increasing prevalence of chronic diseases, particularly conditions such as diabetes, cardiovascular diseases, and renal...